惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

S
Schneier on Security
F
Fortinet All Blogs
博客园_首页
The GitHub Blog
The GitHub Blog
V
Visual Studio Blog
D
DataBreaches.Net
aimingoo的专栏
aimingoo的专栏
爱范儿
爱范儿
B
Blog
Cyber Security Advisories - MS-ISAC
Cyber Security Advisories - MS-ISAC
N
Netflix TechBlog - Medium
阮一峰的网络日志
阮一峰的网络日志
P
Proofpoint News Feed
D
Docker
Engineering at Meta
Engineering at Meta
大猫的无限游戏
大猫的无限游戏
The Cloudflare Blog
罗磊的独立博客
云风的 BLOG
云风的 BLOG
Microsoft Azure Blog
Microsoft Azure Blog
T
The Exploit Database - CXSecurity.com
博客园 - 三生石上(FineUI控件)
量子位
The Last Watchdog
The Last Watchdog
MyScale Blog
MyScale Blog
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
T
The Blog of Author Tim Ferriss
Exploit-DB.com RSS Feed
Exploit-DB.com RSS Feed
小众软件
小众软件
Cloudbric
Cloudbric
博客园 - 司徒正美
H
Help Net Security
人人都是产品经理
人人都是产品经理
Application and Cybersecurity Blog
Application and Cybersecurity Blog
L
LangChain Blog
Latest news
Latest news
M
MIT News - Artificial intelligence
T
Threat Research - Cisco Blogs
博客园 - Franky
S
Security Affairs
W
WeLiveSecurity
F
Full Disclosure
Know Your Adversary
Know Your Adversary
Google DeepMind News
Google DeepMind News
The Hacker News
The Hacker News
Cyberwarzone
Cyberwarzone
美团技术团队
PCI Perspectives
PCI Perspectives
C
Check Point Blog
Spread Privacy
Spread Privacy

World Economic Forum

What happened at the MC14 WTO meeting in Yaoundé How giving gorillas digital wallets can help finance nature Why is leadership a strategic investment for philanthropy? Counting the many costs of the global mental health burden What we learned from the 2026 World Bank Spring Meetings Crop protection is at risk. How innovation can help Here's a playbook for boards on how to govern agentic AI Why connected data makes AI decision-ready for sustainability 3 ways better data practices are reshaping financial supervision What technology convergence looks like in practice 7 reasons the old order broke — and how it might be repaired How governments can make agentic AI re  ? Current and future uses of RNA, including mRNA vaccines Real-time deepfakes are rewriting the rules of child safety Electrification trend ‘unmistakeable’ – and more energy stories Saudi Arabia's new AI-powered sustainability platform could unlock $20 billion by 2030 Here are 6 ways that climate change is affecting sports around the world This crisis could be an opportunity for the energy transition Middle East war: 6 ways countries are responding to the historic energy shock Nature can teach us about leadership and building resilience How did the Strait of Hormuz become so important, and will it stay that way? Yes/Cities: Helping global cities become more resilient, sustainable and prosperous Healthy ageing in APAC: The role of the influenza vaccine Risk management, renewables and a rocky road ahead: Spring Meetings takeaways Japan in a world of rising middle powers EU plans to offset Iran war's energy impact, and other climate and nature news 3 cities leading on green investment for economic growth The coffee industry is making the case for climate insurance The ocean is now a subprime asset, so we need a sustainable blue economy 5 leaders on today’s growth dilemmas and how to navigate them What helps purpose-driven, early-stage start-ups scale? Why trust is key to the EU's Empowering Consumers Directive The $3 trillion maintenance gap is burning money and the planet Surging AI needs and geopolitical supply shocks renew attention on nuclear energy 5 things to know before interacting with digital assets Frontiers Planet Prize: 25 solutions for planetary crises How the Iran war is disrupting India's steel production What's needed for growth in the new economy? Why we need a humanitarian truce is Sudan Freedom of expression under attack: How do we protect the media? Why companies – and nations – should create an AI culture Anthropic’s Mythos moment: how frontier AI is redefining cybersecurity Discover this week's must-read finance stories 'Godfather of AI' Yoshua Bengio on why AI can behave unpredictably (and what needs to change) Everyone talks about critical thinking. Here's how schools should actually teach it The top international trade stories to know this month The big chart: How oil prices have reacted to world events since the 1980s Why AI needs digital public infrastructure to deliver for citizens What AI in education needs next: Lessons from youth leaders across five countries How to scale clean hydrogen to meet energy security needs Meet the Young Global Leaders Class of 2026 Ventures with blue carbon solutions for coastal restoration How peer-led reskilling is helping bridge the skills gap in East Africa China's lessons on the energy sector’s nature-positive transition Here's how Japan's green materials sector is thriving The Strait of Hormuz crisis: Rewriting the future of AI Systemic risk is the hidden tax on growth. Here's how insurance can help build economic resilience Earth Day: What is it, when is it and why is it important? The Rayner plot: What it tells us about the future of jobs This is why we’ll feel the economic effects of this war for a while How energy and finance leaders are approaching climate investment in 2026 How quantum technologies are being tested to strengthen energy systems How to think about ‘safe’ withdrawal rates in a changing global economy Is collective cyber defence the future of port security? Learnings from a Dutch initiative Cyberattacks target US infrastructure, and other cybersecurity news Rethinking workplace energy: Why our assumptions can lead to burnout What could an international panel to tackle inequality achieve? Why climate action matters for healthy longevity Workforce health is the bedrock of global supply chains. Here's how to protect it Southeast Asia may be a distinct region but its risks affect each country differently 5 ways to grow a business mindset in international development How companies can finally cut Scope 3 emissions Here's how to get the $7 trillion AI hardware buildout right Leaders are moving from systems of record to systems of work G7 One Health Summit launches global diagnostics initiative, and other health stories What stopping war-risk insurance in the Strait of Hormuz tells us Why leaders must transform cyber resilience measurement AI can help create comparability and scale impact investing What's in store for the future of multilateralism? Why food waste is a $540 billion opportunity hiding in plain sight What Afghanistan can teach us about strategic foresight This is how we use generative AI on Forum Stories How cities are turning urban complexity into coherent climate plans How non-profits and governments use data to drive real system change How demographics, not AI, will redefine the labour market Three lessons on the energy transition in an age of crisis NFL players: Why financial literacy is a game-changer for student-athletes 3 ways Africa can maximize the value of its critical minerals and finance its future What leaders are saying about the new geopolitics of energy The financial system is rebooting. Stakeholders must adapt Cancer care innovation is reshaping resilience in Japan The hidden struggle of employed youth in Africa How markets and missions are becoming allies for impact What’s changing in frontier tech – from geopolitics to AI and energy Why stablecoins are quickly becoming a geopolitical issue How public-private collaboration can help close the global gender gap It’s time to start treating AI infrastructure as critical infrastructure 5 effective choices to turn workplace well-being into a competitive advantage How to strengthen collaboration to tackle infectious disease Why the AI economy can’t rely on a single digital Suez
From smallpox to the common cold: A brief history of vaccines
Douglas Broo · 2026-04-27 · via World Economic Forum

This article has been updated.

  • The concept of vaccinating people against disease dates back centuries.
  • Today, vaccines save up to 5 million lives every year, and new ones continue to be introduced.
  • To mark World Immunization Week, 24-30 April, we look back at the extraordinary history of vaccines.

Every minute, six lives are saved by vaccines, according to the World Health Organization (WHO), while up to 5 million deaths a year are avoided because of them, says UNICEF. Once-fatal diseases like smallpox have been eliminated and others are largely kept in check with vaccines. But how did this lifesaving breakthrough come about?

The idea of using cells from infectious diseases to stimulate the human body’s immune system to fight them is not new: people were using basic forms of immunization centuries ago, as the timeline below shows.

But the remarkable success of vaccines has not been without its challenges – one of the main ones being misinformation and anti-vaccination sentiment, which can be traced back to the 1850s when smallpox immunization became mandatory in the UK.

As we mark World Immunization Week, which this year reminds people that 'For every generation, vaccines work', let’s look back at some of the milestones in the remarkable journey to a vaccine-protected world.

Early forms of vaccinations

As early as the 1500s, people were using simple forms of vaccinations to create immunity from smallpox, according to Gavi, the global vaccines alliance.

At around the same time, Lady Mary Wortley Montagu, a smallpox survivor and wife of the British ambassador to Turkey, had her three-year-old son inoculated in the city and returned home to promote the benefits of vaccination.

The first modern vaccination

But it was not until 1796 that British country doctor Edward Jenner studied the effects scientifically. Noticing local rural communities that were exposed to cowpox seemed to be immune to smallpox, Jenner first inoculated a child with cowpox matter and then, two months later, injected the same boy with smallpox matter.

Dr Jenner performing his first vaccination, on James Phipps, a boy of 8, May 14 1796.

Edward Jenner depicted giving the world's first ever vaccination. Image: Wellcome Collection gallery

It worked, and historians now refer to it as the first modern vaccination – named after vaccinia, the Latin name for cowpox. Despite its success, the public took a while to come on board, with some even worried that it would turn them into cows. With further testing and evidence of its efficacy, the smallpox vaccine spread to other continents until mandatory vaccination programmes came into effect in Britain and parts of the US during the 1840s and 1850s. The disease was declared eradicated by the WHO in 1980.

Laboratory-produced vaccines

Perhaps best-known today for inventing a method of preserving milk, Louis Pasteur discovered a vaccine against chicken cholera in 1879 after a vial of the virus was mistakenly left open to the elements for a month. Chickens injected with the neglected virus became ill but recovered swiftly.

Pasteur reasoned that the virus had weakened, or attenuated. His accidental discovery opened the door to producing vaccines in the laboratory by creating a less potent form of a virus that would stimulate immunity without harming the patient.

Pasteur went on to develop successful vaccines against anthrax and rabies. In 1885, Spanish doctor Jaime Ferrán created a human cholera vaccine. And in 1896, British and German scientists developed a vaccine against typhoid.

20th-century vaccines

The 1900s witnessed a huge growth in vaccine discovery. The 1920s saw the creation of vaccines against tuberculosis, tetanus and diphtheria. In 1938, South African virologist Max Theiler and his team created a vaccine for yellow fever – Theiler later won a Nobel Prize for his discovery, the first time it had been awarded for a vaccine.

Polio had become one of the most feared diseases in the world during the late 19th and early 20th centuries, with outbreaks killing thousands of people. In 1953, US scientist Jonas Salk created an inactivated polio vaccine, which he first tested on himself and his family. A success, the vaccine was licensed in 1955 and, two years later, cases of polio in the US had dropped from 58,000 to 5,600.

It was also a period in which combination vaccines were introduced – DTP (diphtheria, tetanus and pertussis or whooping cough) in 1948 and MMR (measles, mumps and rubella) in 1971.

The COVID-19 revolution

After the COVID-19 pandemic was confirmed in March 2020, work began on vaccines at astonishing speed and, within 12 months, new vaccines were being tested and approved. The previous fastest vaccine turnaround was six years for mumps.

The speed was the result of groundbreaking previous work on vaccines for HIV, MERS and SARS, which used genetic material to stimulate cells to produce “spike proteins” which create antibodies to fight a virus.

When COVID-19 vaccinations were rolled out globally in 2020-2021, it marked the first time mRNA vaccines had been approved for widespread use. One study estimates the number of lives saved as a result of the various COVID vaccines at 2.5 million. Despite this, there is evidence that confidence in vaccinations more generally has gone down since the pandemic.

The future of vaccinations

The COVID-19 vaccine paved the way for more mRNA vaccines, including most recently, a vaccine to protect against a potential bird flu pandemic.

Researchers are discovering new ways to vaccinate, too. A team at Stanford University has recently tested a "universal vaccine" on mice with positive results. Instead of training the immune system, as vaccines have traditionally done, this new type of vaccine mimics how immune cells communicate with each other. If it successfully translates to humans, a single nasal spray could protect against all coughs, colds and flus, reports the BBC.

The question that the COVID-19 pandemic, in particular, laid bare is – will everyone have access to future vaccines? For Gavi, the focus is on ensuring that no one is left behind when it comes to tackling preventable diseases.

Latest data reveals that lower-income countries contributed over $300 million towards immunization programmes in 2025, a new record and a sign that immunization is being prioritized in national budgets.

“In an increasingly constrained global financing environment, countries are stepping forward to play a lead role in securing the future of immunization,” said Gavi CEO Dr Sania Nishtar. “Record co-financing at this scale demonstrates that the shift toward country-led, sustainable immunization systems is gaining momentum and that we are entering a new era when it comes to protecting children against preventable diseases.”